Mydrilate 0.5% w/v Eye Drops Ireland - English - HPRA (Health Products Regulatory Authority)

mydrilate 0.5% w/v eye drops

riemser pharma gmbh - cyclopentolate hydrochloride - eye drops, solution - 0.5 percent weight/volume - anticholinergics; cyclopentolate

Mydrilate 1.0% w/v Eye Drops Ireland - English - HPRA (Health Products Regulatory Authority)

mydrilate 1.0% w/v eye drops

riemser pharma gmbh - cyclopentolate hydrochloride - eye drops, solution - 1.0 percent weight/volume - anticholinergics; cyclopentolate

Xylocaine 1% with Adrenaline 1:100,000 New Zealand - English - Medsafe (Medicines Safety Authority)

xylocaine 1% with adrenaline 1:100,000

pharmacy retailing (nz) ltd t/a healthcare logistics - adrenaline acid tartrate 0.018 mg equivalent to 10 µg adrenaline;  ; lidocaine hydrochloride monohydrate 10.7 mg equivalent to 10 mg lignocaine hydrochloride anhydrous; adrenaline acid tartrate 0.018 mg equivalent to 10 µg adrenaline; lidocaine hydrochloride monohydrate 10.7 mg equivalent to 10 mg lignocaine hydrochloride anhydrous - solution for injection - active: adrenaline acid tartrate 0.018 mg equivalent to 10 µg adrenaline   lidocaine hydrochloride monohydrate 10.7 mg equivalent to 10 mg lignocaine hydrochloride anhydrous excipient: hydrochloric acid as 2m solution for ph adjustment (ph 3.3-5.0) methyl hydroxybenzoate sodium chloride sodium hydroxide as 2m solution for ph adjustment (ph 3.3-5.0) sodium metabisulfite water for injection active: adrenaline acid tartrate 0.018 mg equivalent to 10 µg adrenaline lidocaine hydrochloride monohydrate 10.7 mg equivalent to 10 mg lignocaine hydrochloride anhydrous excipient: hydrochloric acid as 2m solution for ph adjustment nitrogen as nitrogen for injection sodium chloride sodium hydroxide as 2m solution for ph adjustment sodium metabisulfite water for injection

Xylocaine 1% with Adrenaline 1:200,000 New Zealand - English - Medsafe (Medicines Safety Authority)

xylocaine 1% with adrenaline 1:200,000

pharmacy retailing (nz) ltd t/a healthcare logistics - adrenaline acid tartrate 0.0091 mg/ml equivalent to 5 µg/ml adrenaline;  ; lidocaine hydrochloride 10 mg/ml; adrenaline acid tartrate 0.0091 mg/ml ([=5mcg/ml adrenaline]); lidocaine hydrochloride 10 mg/ml; adrenaline acid tartrate 0.0091 mg/ml ([=5mcg/ml adrenaline]); lidocaine hydrochloride 10 mg/ml - solution for injection - active: adrenaline acid tartrate 0.0091 mg/ml equivalent to 5 µg/ml adrenaline   lidocaine hydrochloride 10 mg/ml excipient: hydrochloric acid as 2m solution for ph adjustment (ph 3.3-5.0) methyl hydroxybenzoate sodium chloride sodium hydroxide as 2m solution for ph adjustment (ph 3.3-5.0) sodium metabisulfite water for injection active: adrenaline acid tartrate 0.0091 mg/ml ([=5mcg/ml adrenaline]) lidocaine hydrochloride 10 mg/ml excipient: carbon dioxide hydrochloric acid sodium chloride sodium metabisulfite water for injection active: adrenaline acid tartrate 0.0091 mg/ml ([=5mcg/ml adrenaline]) lidocaine hydrochloride 10 mg/ml excipient: carbon dioxide hydrochloric acid sodium chloride sodium hydroxide sodium metabisulfite water for injection - xylocaine solutions are indicated for the production of local or regional anaesthesia by the following techniques: · local infiltration · minor or major nerve blocks · epidural block · arthroscopy · intravenous regional anaesthesia

Xylocaine 2% with Adrenaline 1:200,000 New Zealand - English - Medsafe (Medicines Safety Authority)

xylocaine 2% with adrenaline 1:200,000

pharmacy retailing (nz) ltd t/a healthcare logistics - adrenaline acid tartrate 0.0091 mg/ml;  ; lidocaine hydrochloride 20 mg/ml; adrenaline acid tartrate 0.0091 mg/ml; lidocaine hydrochloride 20 mg/ml - solution for injection - active: adrenaline acid tartrate 0.0091 mg/ml   lidocaine hydrochloride 20 mg/ml excipient: hydrochloric acid sodium chloride sodium metabisulfite water for injection active: adrenaline acid tartrate 0.0091 mg/ml lidocaine hydrochloride 20 mg/ml excipient: hydrochloric acid sodium chloride sodium hydroxide sodium metabisulfite water for injection - xylocaine solutions are indicated for the production of local or regional anaesthesia by the following techniques: · local infiltration · minor or major nerve blocks · epidural block · arthroscopy · intravenous regional anaesthesia

CO MYCOPHENOLATE TABLET Canada - English - Health Canada

co mycophenolate tablet

cobalt pharmaceuticals company - mycophenolate mofetil - tablet - 500mg - mycophenolate mofetil 500mg - immunosuppressive agents

Deximune 100 mg  Soft Capsules Ireland - English - HPRA (Health Products Regulatory Authority)

deximune 100 mg soft capsules

dexcel pharma gmbh - ciclosporin - capsule, soft - 100 milligram(s) - calcineurin inhibitors; ciclosporin

Deximune 50 mg soft capsules Ireland - English - HPRA (Health Products Regulatory Authority)

deximune 50 mg soft capsules

dexcel pharma gmbh - ciclosporin - capsule, soft - 50 milligram(s) - calcineurin inhibitors; ciclosporin

Deximune 25 mg Soft Capsules Ireland - English - HPRA (Health Products Regulatory Authority)

deximune 25 mg soft capsules

dexcel pharma gmbh - ciclosporin - capsule, soft - 25 milligram(s) - calcineurin inhibitors; ciclosporin